mRNA Vaccine and Therapeutics Market Size is Anticipated to Reach USD 17,036 Million by 2035

According to a recently published report by Roots Analysis, given the rapid and growing awareness of mRNA-based vaccines and therapeutics coupled with their vast potential in emerging therapeutic has position the industry strongly for future expansion.

mRNA vaccine and Therapeutics Market Overview

The mRNA vaccines and therapeutics market is expected to reach USD 17,036 million by 2035, growing at a CAGR of 131% during the forecast period till 2035.

mRNA has emerged as one of the key therapeutic modalities in the modern healthcare industry as it carries genetic information from the DNA to ribosomes for the production of functional proteins. The success of mRNA-based products came to the forefront during the COVID-19 pandemic, with the successful development and widespread use of mRNA vaccines (namely COMIRNATY and Spikevax). Owing to this success, the demand of mRNA synthesis and manufacturing has increased significantly, prompting various mRNA therapeutic / vaccine developers to actively explore avenues that enable them to meet the existing demand. Further, the ongoing research in this domain has expanded the therapeutic applications of mRNA beyond infectious diseases, to autoimmune, genetic and oncological disorders, creating several opportunities for the stakeholders engaged in this domain.

Browse 150+ figures and 130+ market data tables spread across 400+ pages and detailed Table of Content on “mRNA Vaccine and Therapeutics Market (4th Edition): Industry Trends and Global Forecasts, till 2035 by Application Area (COVID-19 and non-COVID indications), Target Disease Indication (Cystic Fibrosis, Influenza, Melanoma, Metastatic/ R/R Head and Neck Cancer, Mononucleosis, Muscle-Invasive Urothelial Carcinoma, Non-Small Cell Lung Cancer, Norovirus Acute Gastroenteritis, Propionic Acidemia and RSV infection) and Geographical Regions (North America, Europe and Asia-Pacific)” here: https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html

Market Drivers

Several factors are propelling mRNA vaccine and therapeutics market growth. One of the mRNA vaccine market growth drivers is expanding therapeutic applications and increasing extent of outsourcing in this domain. Notably, the success of COVID-19 mRNA vaccines has led to the increased demand for mRNA development due to the vaccines' proven efficacy and potential for rapid development. This success has built confidence among investors, regulators, and the public, resulting in increased research and commercial interest in mRNA therapeutics and vaccines across a myriad of diseases.

Market Restraints

Even if the global mRNA vaccine market size is expanding significantly, there are several obstacles that could prevent the sector from expanding. Stability and storage-related issues are among the main obstacles, greatly raising the operational complexity and expenses of mRNA vaccines and treatments. Further discouraging widespread adoption, especially among small and medium-sized mRNA companies, are the high production costs of mRNA-based goods. Further impeding the market's expansion are worries over long-term safety and effectiveness in medicinal applications. When taken as a whole, these elements provide obstacles to broader acceptance and make it difficult for the market to continue growing.

Growth Factors

Despite the restraints, mRNA vaccine market growth drivers help the market grow at a steady pace. One notable factor is its emerging applications in personalized medicine, creating significant opportunities for market expansion as novel treatment modalities can be explored for a wide array of disorders. Further, the increasing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and genetic conditions has significantly driven mRNA vaccine and therapeutics market trends as such therapies offer targeted treatment options with a capability to address complex, previously untreatable diseases. Owing to the aforementioned factors, it can be anticipated that the mRNA vaccine and therapeutics market will flourish remarkably in the foreseen future.

mRNA Vaccine and Therapeutics Market Segments

Based on the application area, the market is segmented into COVID and non-COVID indications.

• The COVID indication sub-segment led the mRNA vaccines and therapeutics market, capturing the largest revenue share in the current year.    
• The non-COVID indication sub-segment is anticipated to show the highest growth rate of 131.1% CAGR during the forecast period.

Based on the target indication, the market is segmented into Cystic Fibrosis, Influenza, Melanoma, Metastatic/ R/R Head and Neck Cancer, Mononucleosis, Muscle-Invasive Urothelial Carcinoma, Non-Small Cell Lung Cancer, Norovirus Acute Gastroenteritis, Propionic Acidemia and RSV infection.

• RSV infections sub-segment led the mRNA vaccines and therapeutics market, capturing the largest revenue share of 100% in the current year.
• The Non-Small Cell Lung Cancer sub-segment is anticipated to show the highest CAGR of 148.7% during the forecast period.

Based on the regional insights, the market is segmented into North America, Europe and Asia-Pacific

• North America dominated the mRNA vaccines and therapeutics market and accounted for the largest revenue share of 75% in the current year.
• In North America, the mRNA vaccines and therapeutics market is anticipated to demonstrate lucrative growth, with CAGR of 107.5% during the forecast period.

Key Companies Profiled

The mRNA vaccines and therapeutics market report also includes detailed profiles of key companies (listed below) that are engaged in the mRNA vaccines and therapeutics domain:

• Moderna
• BioNTech
• Providence Therapeutics
• Suzhou Abogen Biosciences
• CureVac
• RNAimmune (Subsidiary of Sirnaomics)
• Turn Biotechnologies
• Arcturus Therapeutics
• Walvax

You Can Download Free Sample PDF Copy of This Report At: https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the market research. Having worked with over 1,500 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com